BTG3 and synovial sarcoma: ATD (17%), SLE (2.0%), SS (2.0%), MG (2%), RA (1.3%); ANA (43%), ENA (15%), SS-A (10%), SS-B (3%); and rheumatoid factor (5%), AChR antibodies (11%)